BWM
DXCM icon

Baystate Wealth Management’s DexCom DXCM Stock Holding History

Baystate Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$62.9K Buy
+507
New +$51.8K ﹤0.01% 344

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baystate Wealth Management's DXCM Position: Q4 2023 in Review

Baystate Wealth Management opened a new position in DexCom (DXCM) in Q4 2023: 507 shares worth $62.9K. The stake represents ﹤0.01% of the portfolio and ranks #344 among its holdings.

974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Baystate Wealth Management held 507 shares of DexCom worth $62.9K as of Q4 2023.
  • DexCom was a new Baystate Wealth Management position in Q4 2023.
  • DexCom made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #344 holding.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.